Literature DB >> 22577772

Involvement of CD24 in angiogenesis in a mouse model of oxygen-induced retinopathy.

Hadas Newman1, Shiran Shapira, Oriel Spierer, Sarah Kraus, Mordechai Rosner, Sarah Pri-Chen, Anat Loewenstein, Nadir Arber, Adiel Barak.   

Abstract

PURPOSE: To investigate a possible involvement of CD24 in vascular remodeling and angiogenesis in retinopathy of prematurity (ROP) in a mouse model of oxygen-induced retinopathy.
MATERIALS AND METHODS: 17 CD24 knockout (KO) and 12 wild-type (WT) C57BL/6 mice were used. Group 1 mice were exposed to oxygen concentrations of 75 ± 2% from postnatal day (P) 7 to P12. Group 2 mice were raised in room air. At P17, all mice underwent fluorescein-conjugated-dextran perfusion and were sacrificed. The flat-mounted retinas were scored manually and digitally by a new computerized algorithm, according to blood vessel obliteration, tortuosity, vascular tufts and neovascularization formation.
RESULTS: Fifty four retinal whole mounts were available for analysis and scoring. Group 1 retinas had significantly higher values of vaso-obliteration, tufts, neovascularization, vessel tortuosity and higher mean retinopathy scores than Group 2 retinas (KO mice: 9.0 ± 0.27 vs. 0.74 ± 0.2, respectively, P < 0.0001; WT mice: 7.58 ± 0.40 vs. 1.17 ± 0.27, respectively, P < 0.0001). Manual scoring in Group 1 revealed higher values of neovascularization, tortuosity and mean retinopathy scores in KO mice vs. WT mice (9.0 ± 0.27 vs. 7.58 ± 0.40, respectively, P = 0.009). Digital scoring revealed a higher neovascularization score in KO mice as well (13.72 ± 0.82% vs. 8.06 ± 0.27%, P < 0.0001). All mice had similar vaso-obliteration areas. There were no significant differences between KO and WT mice in Group 2.
CONCLUSIONS: Absence of CD24 may have a deleterious effect on angiogenesis occurring in the second stage of ROP development, though its role in vessel obliteration during the first stage of ROP is probably limited.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22577772     DOI: 10.3109/02713683.2011.647226

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  4 in total

1.  Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.

Authors:  J Tang; H Cai; L Lin; P Xie; W Zhong; M Tang
Journal:  Clin Transl Oncol       Date:  2012-11-10       Impact factor: 3.405

2.  CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.

Authors:  Tomohito Tanaka; Yoshito Terai; Yuhei Kogata; Keisuke Ashihara; Kazuya Maeda; Satoe Fujiwara; Saha Yoo; Yoshimichi Tanaka; Satoshi Tsunetoh; Hiroshi Sasaki; Masanori Kanemura; Akiko Tanabe; Masahide Ohmichi
Journal:  Oncol Rep       Date:  2015-09-08       Impact factor: 3.906

3.  Downregulation of CD24 suppresses bone metastasis of lung cancer.

Authors:  Hinako Okabe; Katsuhiko Aoki; Satomi Yogosawa; Mitsuru Saito; Keishi Marumo; Kiyotsugu Yoshida
Journal:  Cancer Sci       Date:  2017-11-29       Impact factor: 6.716

4.  CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer.

Authors:  Xinying Wang; Yu Zhang; Yingying Zhao; Yanling Liang; Cheng Xiang; Huanyu Zhou; Hui Zhang; Qiang Zhang; Haitao Qing; Bo Jiang; Huabao Xiong; Liang Peng
Journal:  Oncotarget       Date:  2016-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.